Actively Recruiting
Study of Preoperative GDF-15 Levels and Early Outcomes After Left Ventricular Assist Device Implantation in Adults with Advanced Heart Failure
Led by Akdeniz University · Updated on 2026-03-27
48
Participants Needed
1
Research Sites
19 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to explore how preoperative levels of growth differentiation factor-15 GDF-15, a biomarker linked to inflammation and heart injury, relate to early outcomes after left ventricular assist device LVAD implantation in patients with advanced heart failure. The study focuses on whether higher GDF-15 levels before surgery are connected to complications or mortality soon after the procedure. Understanding this may help improve how doctors assess risk and select patients for LVAD implantation. The study observes patients undergoing LVAD implantation, measuring their GDF-15 levels before surgery. There are no assigned treatments or interventions as this is an observational study. Researchers will track early postoperative outcomes including complications and mortality within 30 days after the LVAD implantation to see if these outcomes are linked to pre-surgery GDF-15 levels. Participants will have their blood tested for GDF-15 before the surgery and will be monitored closely for any complications or death during the first month after the procedure. Data collection includes clinical evaluations and outcome tracking up to 30 days post-implantation. This study helps to identify patients at higher risk and may provide valuable information for improving care and decision-making around LVAD implantation. Total participation lasts through the initial hospitalization and early recovery period.
CONDITIONS
Brief Title
GDF-15 and Early Outcomes After LVAD Implantation
Research Team
E
emel gündüz, md
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here